The advantages of methotrexate in treating COVID-19 are summarized as follows: (a) methotrexate achieves true multi-targeting in COVID-19, by inhibiting multiple targets from diverse protein families like proteases (furin), reductases (DHFR), synthases (TYMS) and transformylase (ATIC). The gene discussed is TYMS; the disease is COVID-19.